298 related articles for article (PubMed ID: 36286841)
1. [The value of a low-protein diet and ketoanalogues of essential amino acids in the сontrol of protein carbamylation and toxic effects of urea in chronic kidney disease].
Mikhailova NA
Ter Arkh; 2021 Jun; 93(6):729-735. PubMed ID: 36286841
[TBL] [Abstract][Full Text] [Related]
2. Urea, a true uremic toxin: the empire strikes back.
Lau WL; Vaziri ND
Clin Sci (Lond); 2017 Jan; 131(1):3-12. PubMed ID: 27872172
[TBL] [Abstract][Full Text] [Related]
3. The Microbiome and Protein Carbamylation: Potential Targets for Protein-Restricted Diets Supplemented with Ketoanalogues in Predialysis Chronic Kidney Disease.
Faerber V; Kuhn KS; Garneata L; Kalantar-Zadeh K; Kalim S; Raj DS; Westphal M
Nutrients; 2023 Aug; 15(16):. PubMed ID: 37630693
[TBL] [Abstract][Full Text] [Related]
4. Uremic Toxins, Oxidative Stress, Atherosclerosis in Chronic Kidney Disease, and Kidney Transplantation.
Wojtaszek E; Oldakowska-Jedynak U; Kwiatkowska M; Glogowski T; Malyszko J
Oxid Med Cell Longev; 2021; 2021():6651367. PubMed ID: 33628373
[TBL] [Abstract][Full Text] [Related]
5. Uremic Toxins and Their Relation with Oxidative Stress Induced in Patients with CKD.
Pieniazek A; Bernasinska-Slomczewska J; Gwozdzinski L
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34201270
[TBL] [Abstract][Full Text] [Related]
6. Protein carbamylation in kidney disease: pathogenesis and clinical implications.
Kalim S; Karumanchi SA; Thadhani RI; Berg AH
Am J Kidney Dis; 2014 Nov; 64(5):793-803. PubMed ID: 25037561
[TBL] [Abstract][Full Text] [Related]
7. Targeting Uremic Toxins to Prevent Peripheral Vascular Complications in Chronic Kidney Disease.
Wu CL; Tarng DC
Toxins (Basel); 2020 Dec; 12(12):. PubMed ID: 33419312
[TBL] [Abstract][Full Text] [Related]
8. Indoxyl Sulfate-Induced Macrophage Toxicity and Therapeutic Strategies in Uremic Atherosclerosis.
Wakamatsu T; Yamamoto S; Yoshida S; Narita I
Toxins (Basel); 2024 May; 16(6):. PubMed ID: 38922148
[TBL] [Abstract][Full Text] [Related]
9. The Impact of CKD on Uremic Toxins and Gut Microbiota.
Rysz J; Franczyk B; Ławiński J; Olszewski R; Ciałkowska-Rysz A; Gluba-Brzózka A
Toxins (Basel); 2021 Mar; 13(4):. PubMed ID: 33807343
[TBL] [Abstract][Full Text] [Related]
10. Food-Derived Uremic Toxins in Chronic Kidney Disease.
Lauriola M; Farré R; Evenepoel P; Overbeek SA; Meijers B
Toxins (Basel); 2023 Feb; 15(2):. PubMed ID: 36828430
[TBL] [Abstract][Full Text] [Related]
11. The Role of Uremic Retention Solutes in the MIA Syndrome in Hemodialysis Subjects.
Ciceri P; Artioli L; Magagnoli L; Barassi A; Alvarez JC; Massy ZA; Galassi A; Cozzolino M
Blood Purif; 2023; 52(1):41-53. PubMed ID: 35512641
[TBL] [Abstract][Full Text] [Related]
12. Molecular mechanisms underlying uremic toxin-related systemic disorders in chronic kidney disease: focused on β
Yamamoto S
Clin Exp Nephrol; 2019 Feb; 23(2):151-157. PubMed ID: 29869756
[TBL] [Abstract][Full Text] [Related]
13. Cardiotoxicity of Uremic Toxins: A Driver of Cardiorenal Syndrome.
Lekawanvijit S
Toxins (Basel); 2018 Sep; 10(9):. PubMed ID: 30200452
[TBL] [Abstract][Full Text] [Related]
14. [Role of protein carbamylation in chronic kidney disease complications].
Gillery P; Jaisson S; Gorisse L; Pietrement C
Nephrol Ther; 2015 Jun; 11(3):129-34. PubMed ID: 25794932
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular burden associated with uremic toxins in patients with chronic kidney disease.
Moradi H; Sica DA; Kalantar-Zadeh K
Am J Nephrol; 2013; 38(2):136-48. PubMed ID: 23941724
[TBL] [Abstract][Full Text] [Related]
16. The New Nordic Renal Diet Induces a Pronounced Reduction of Urine Acid Excretion and Uremic Toxins in Chronic Kidney Disease Patients (Stage 3 and 4).
Hansen NM; Berg P; Rix M; Pareek M; Leipziger J; Kamper AL; Astrup A; Vaarby Sorensen M; Salomo L
J Ren Nutr; 2023 May; 33(3):412-419. PubMed ID: 36195272
[TBL] [Abstract][Full Text] [Related]
17. Role of Uremic Toxins in Early Vascular Ageing and Calcification.
Kyriakidis NC; Cobo G; Dai L; Lindholm B; Stenvinkel P
Toxins (Basel); 2021 Jan; 13(1):. PubMed ID: 33401534
[TBL] [Abstract][Full Text] [Related]
18. Protein carbamylation and chronic kidney disease progression in the Chronic Renal Insufficiency Cohort Study.
Kalim S; Berg AH; Karumanchi SA; Thadhani R; Allegretti AS; Nigwekar S; Zhao S; Srivastava A; Raj D; Deo R; Frydrych A; Chen J; Sondheimer J; Shafi T; Weir M; Lash JP;
Nephrol Dial Transplant; 2021 Dec; 37(1):139-147. PubMed ID: 33661286
[TBL] [Abstract][Full Text] [Related]
19. Altered microbiome in chronic kidney disease: systemic effects of gut-derived uremic toxins.
Lau WL; Savoj J; Nakata MB; Vaziri ND
Clin Sci (Lond); 2018 Mar; 132(5):509-522. PubMed ID: 29523750
[TBL] [Abstract][Full Text] [Related]
20. Role of the Gut Microbiome in Uremia: A Potential Therapeutic Target.
Ramezani A; Massy ZA; Meijers B; Evenepoel P; Vanholder R; Raj DS
Am J Kidney Dis; 2016 Mar; 67(3):483-98. PubMed ID: 26590448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
